Drug Shortage Report for JAMP-EFAVIRENZ
Report ID | 158082 |
Drug Identification Number | 02458233 |
Brand name | JAMP-EFAVIRENZ |
Common or Proper name | Efavirenz tablets, USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | EFAVIRENZ |
Strength(s) | 600MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets (bottle) |
ATC code | J05AG |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-04-01 |
Estimated end date | 2022-06-23 |
Actual end date | 2022-07-19 |
Shortage status | Resolved |
Updated date | 2022-07-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2022-07-20 | English | Compare |
v8 | 2022-07-19 | French | Compare |
v7 | 2022-07-19 | English | Compare |
v6 | 2022-06-13 | French | Compare |
v5 | 2022-06-13 | English | Compare |
v4 | 2022-05-17 | French | Compare |
v3 | 2022-05-17 | English | Compare |
v2 | 2022-04-06 | French | Compare |
v1 | 2022-04-06 | English | Compare |
Showing 1 to 9 of 9